DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20190672

Prevalence of obesity and prediabetes in above 40 years age group based on glycated hemoglobin levels among health care professional in Patna, India

Amrandra Prasad Singh

Abstract


Background: This study aimed to assess the prevalence of prediabetes using glycated hemoglobin (HbA1c) in above 40 years age group health care professional in Patna.

Methods: This was a cross sectional study carried out amongst 315 employees of the Independent Public Central Hospital in Patna. The selection of healthcare professionals for the study was random. The largest study subgroup (63.4%) were nurses, followed by word attender (13.5%), other administrative employee (10.3%), and orderlies (6.6%). All subjects underwent glycated hemoglobin level measurement at hospital laboratory. Data were analysed using descriptive statistics, chi-square and binary logistic regression tests at value of p <0.05.

Results: The study group was evaluated for prediabetes (expressed in the form of HbA1c levels) with an American Diabetes Association-approved classification. The results indicated that a vast majority of the evaluated healthcare personnel (383 people; 82.4%) had normal glycated hemoglobin levels. The remainder of the study group showed carbohydrate metabolism disturbances. The range of glycated hemoglobin levels (5.7-6.4%) found in 73 people (15.7%) suggested an increased risk for diabetes. As a result of the study, as few, or as many, as 9 people (1.9%) were diagnosed with diabetes (initial diagnosis).

Conclusions: These results emphasize the need to develop an urgent public program to improve the detection, prevention, and treatment of diabetes. Most of the evaluated healthcare professionals (79.36%) showed no evidence of being at risk for type 2 diabetes mellitus. Only 17.6% of respondents were unaware of their metabolic disturbances. The study demonstrated a positive correlation between body mass index values and glycated hemoglobin levels in the evaluated group of healthcare professionals (R=0.3), which was similar to that found in the general population.


Keywords


BMI, Healthcare, HbA1c, Obesity, Prediabetes

Full Text:

PDF

References


King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diab Care. 1998 Sep 1;21(9):1414-31.

Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diab Med. 1997 Dec;14(S5):S7-85.

Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Eng J Med. 2001 May 3;344(18):1343-50.

Schlienger JL, Type 2 diabetes complications. Presse Med. 2013 May;42(5):839-48.

American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diab Care. 2003 Jan;26 Suppl 1:S33-50.

Statistical Results About Cause of Death. 2003. Daejeon, Korea, National Statistical Office, 2004.

Roman SH, Harris MI. Management of diabetes mellitus from a public health perspective. Endocrinol Metab Clin. 1997 Sep 1;26(3):443-74.

Strojek K, Potyralska MM. Evaluation of the usefulness of HbA1c measurement for diagnosing diabetes in a selected sample of the Polish population. Clin Diabetol. 2014;3(2):51-6.

Czech A. Urgent need for prevention in the practice of sociomedical care for people with type 2 diabetes world and Poland. Metab Med. 2010;14:10-5.

Raz I. Guideline approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2013;36 (Suppl 2):S139-44.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12;352(9131):837-53.

UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-65.